HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants

Haematologica

Volumn 94, Issue 10, 2009, Pages 1465-

  Barton, James C ^a,b   Leiendecker Foster, Catherine ^c   Li, Honggui ^a   DelRio LaFreniere, Susie ^c   Acton, Ronald T ^d   Eckfeldt, John H ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; FERRITIN; HEPCIDIN; ANTIMICROBIAL CATIONIC PEPTIDE;

BETA THALASSEMIA; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LETTER; MAJOR CLINICAL STUDY; PROMOTER REGION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; GENETICS; HEMOCHROMATOSIS; MALE; MUTATION; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON OVERLOAD; MALE; MUTATION; PROMOTER REGIONS, GENETIC;

EID: 70349637638     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.011486     Document Type: Letter

References (6)

1. Island ML, Jouanolle AM, Mosser A, Deugnier Y, David V, Brissot P, et al. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis. Haematologica 2009;94:720-724
2. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778 (Pubitemid 40570925)
3. Wang X, Leiendecker-Foster C, Acton RT, Barton JC, McLaren CE, McLaren GD, et al. Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis 2009;42:150-154
4. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802. (Pubitemid 33145024)
5. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med 2009;87:471-480
6. Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007;92:1037-1042 (Pubitemid 350144209)